13F Insight
DOSSIER · 13F Holders · Q2 2026

LEXICON PHARMACEUTICALS INC

161 institutions still hold LEXICON PHARMACEUTICALS INC as of Q2 2026. Tracked across SEC 13F-HR filings, with insider and 13D/G activity surfaced alongside.

CUSIP 528872302·161 13F holders·last filed Jun 30, 2026
Market cap
—
13F value held
$842M
visible holders
Holders
161
filers reporting
Concentration
49.95%
Artal Group S.A. #1
top holder share
AI Holders Summary · Q2 2026

161 institutions reported LEXICON PHARMACEUTICALS INC in Q2 2026. Artal Group S.A. leads at 49.9% of the visible book.

Top holders

Sorted by position value. Source: SEC EDGAR 13F-HR filings.

#HolderValueShares% port.Quarter
01
Artal Group S.A.
CIK 0001053906
$420M175.2M45.15%Q2 202602
FMR LLC
CIK 0000315066
$124M51.8M0.01%Q2 202603
Siren, L.L.C.
CIK 0002005245
$106M44.3M2.15%Q2 202604
Sessa Capital IM, L.P.
CIK 0001595849
$46M19.0M0.76%Q2 202605
BlackRock, Inc.
CIK 0002012383
$42M17.3M0.00%Q2 202606
VANGUARD CAPITAL MANAGEMENT LLC
CIK 0002100119· Index
$24M9.9M0.00%Q2 202607
GEODE CAPITAL MANAGEMENT, LLC
CIK 0001214717· Index
$15M6.2M0.00%Q2 202608
Point72 Asset Management, L.P.
CIK 0001603466
$12M7.8M0.02%Q1 202609
STATE STREET CORP
CIK 0000093751
$12M4.9M0.00%Q2 202610
Vanguard Portfolio Management
CIK 0002100121· Index
$6M2.4M0.00%Q2 202611
JANE STREET GROUP, LLC
CIK 0001595888· Market maker
$5M3.2M0.00%Q1 202612
NORTHERN TRUST CORP
CIK 0000073124· Index
$5M2.0M0.00%Q2 202613
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
CIK 0000884546· Index
$5M2.0M0.00%Q2 202614
VANGUARD FIDUCIARY TRUST CO
CIK 0000933478· Index
$4M1.6M0.00%Q2 202615
SUSQUEHANNA INTERNATIONAL GROUP, LLP
CIK 0001446194· Market maker
$3M1.4M0.00%Q2 202616
Ishara Investments LP
CIK 0002111609
$3M1.3M2.24%Q2 202617
MILLENNIUM MANAGEMENT LLC
CIK 0001273087
$3M1.1M0.00%Q2 202618
RENAISSANCE TECHNOLOGIES LLC
CIK 0001037389
$3M1.1M0.00%Q2 202619
CITADEL ADVISORS LLC
CIK 0001423053
$3M2.3M0.00%Q4 202520
MACKENZIE FINANCIAL CORP
CIK 0000919859
$2M963K0.00%Q2 2026
Page 1 of 9
141 more holders available. Log in →